MedPath

Weight loss surgery and changes in bone marrow fat and bone mass.

Conditions
ObesitySurgery induced weight lossOsteoporosis
Registration Number
NL-OMON23764
Lead Sponsor
Academic Medical Center, Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

* Female sex

* Age: 18-55 years50 years and older

Exclusion Criteria

* Contraindications to MRI scanning

* Use of bone-modifying or adipose tissue-modifying drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
* Vertebral bone marrow fat fraction measured by QSCI<br /><br>* Vertebral bone mineral density measured by QCT
Secondary Outcome Measures
NameTimeMethod
Bone turnover markers (CTx, P1NP, osteocalcin), 25-hydroxy vitamin D, parathyroid hormone, calcium, albumin, phosphate, alkaline phosphatase, creatinin, complete blood count (CBC), reticulocytes, leptin, adiponectin
© Copyright 2025. All Rights Reserved by MedPath